Liquidia Corporation (LQDA): Wutah pendapatan kuartal marang kuartal

Logo korporat perusahaan Liquidia Corp (LQDA)

The fate of Liquidia Corporation (LQDA) in the orphan drug niche depends on victories in patent disputes with industry behemoths, and the quarterly revenue growth rate on GURU.Markets reflects these risks. The value of 315.40 represents the current level of the metric. Liquidia Corporation relies on protected distribution channels for inhalation agents, while the inertia of commercial implementation for pulmonary hypertension drugs ensures a stable financial inflow.

Liquidia Corp (LQDA) - Wutah pendapatan triwulanan saka 04.07.2022 nganti 20.11.2026

Rincian metrik keuangan lan pasar Liquidia (LQDA)

- rega saham lan target rega konsensus:
- indikator dhuwit lan ilining kas:
Analisis fundamental perusahaan:Liquidia Inc. (LQDA)
Produk sing diprodhuksi liquidia.com

Liquidia Corporation (LQDA) operates in a state of constant legal warfare over patents, rendering the commercial implementation of inhalation drugs dependent on judicial rulings. The calculated quarterly revenue growth rate mathematically captures the effectiveness of these adaptations by measuring the relative increase in sales cash flow compared to the previous period. By analyzing the quarterly revenue growth trend, an investor determines the fundamental vector of business expansion, separating market noise from real growth.

Pesaing Liquidia Corporation (LQDA)

HLN - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal kenvue.com|Verona Pharma (VRNA) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Jyong Biotech Limited (MENS)|LGND (Ligand Pharmaceuticals Incorporated) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Amneal Pharmaceuticals Inc AMRX|Wutah pendapatan triwulanan PRGO|Owah-owahan dodolan kuartal marang kuartal ALVO|Wutah pendapatan triwulanan GLPG (glpg.com)|Tambahing pendapatan triwulanan ANIP|MNKD - Wutah pendapatan kuartal marang kuartal|Amphastar - Owah-owahan dodolan kuartal marang kuartal|PCRX: Wutah pendapatan triwulanan|ars-pharma.com - Tambahing pendapatan triwulanan|TBPH (Theravance Biopharma Inc) - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal Aquestive Pharma AQST|Wutah pendapatan triwulanan SCPH|Owah-owahan dodolan kuartal marang kuartal TECX|Wutah pendapatan kuartal marang kuartal tonixpharma.com TNXP|SXTC (SXT China) - Dinamika pendapatan kuartal marang kuartal|Eupraxia Pharmaceuticals - Wutah pendapatan triwulanan|Tingkat wutah dodolan sajrone kuartal BioHarvest Sciences Inc. BHST|EXOZ: Wutah pendapatan triwulanan|Oramed (ORMP) - Wutah pendapatan triwulanan|ENTX (Entera Bio) - Wutah pendapatan triwulanan|ipatherapeutics.com (HYFT) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Tingkat wutah pendapatan sajrone kuartal|TELO: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Wutah pendapatan kuartal marang kuartal|RLYB - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan kuartal marang kuartal Lexaria Bioscience|Pulmatrix Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal ftzy.com.cn (PTHL)|Aptorum Group - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan LYRA (Lyra Therapeutics Inc.)|Tingkat wutah dodolan sajrone kuartal Impact BioMedical (IBO)|TNF Pharmaceuticals - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal cbdMD Inc.|PainReform Ltd. (PRFX) - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Altamira Therapeutics (CYTO)|Wutah pendapatan kuartal marang kuartal Lipella Pharmaceuticals, Inc.|OPTN: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Pieris (PIRS)|Wutah pendapatan triwulanan Procaps Group Corp (PROC)|Wutah pendapatan triwulanan PTPI (petrospharma.com)|Tambahing pendapatan triwulanan QLI|ACELYRIN - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan TFFP (TFF Pharmaceuticals Inc.)